Related Experiment Video
Updated: Aug 19, 2025
14:57
Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
94.3K
Acetylcholine deficit causes dysfunctional inhibitory control in an aging-dependent manner.
Paul Rafael Sabandal1, Erick Benjamin Saldes2, Kyung-An Han3
1Department of Biological Sciences, University of Texas at El Paso, El Paso, TX, 79968, USA. pbsabandal@utep.edu.
Scientific Reports
|December 3, 2022
Summary
Aging reduces inhibitory control, a key executive function. This study in flies reveals acetylcholine
Area of Science:
- Neuroscience
- Aging Research
- Cognitive Function
Background:
- Inhibitory control, essential for goal-directed behavior, declines with aging and dementia.
- Acetylcholine signaling is vital for executive function and decreases with age.
- The precise role of acetylcholine in age-related inhibitory decline is not well understood.
Purpose of the Study:
- To investigate the contribution of acetylcholine to the decline in inhibitory control during aging.
- To identify neural circuits involved in age-associated deficits in inhibition.
Main Methods:
- Utilized a Go/No-Go task in Drosophila (fruit flies) to assess inhibition capacity.
- Manipulated acetylcholine breakdown and biosynthesis pathways.
- Examined the role of specific neural populations, including mushroom body (MB) neurons.
Main Results:
- Inhibition capacity declines with age in wild-type flies.
- Reducing acetylcholine breakdown mitigated age-related inhibition decline.
- Reducing acetylcholine biosynthesis exacerbated the decline.
- Mushroom body (MB) γ neurons are identified as a key site for acetylcholine's role in this deficit.
- MBON-γ2α'1 neurons are critical for sustained movement suppression.
Conclusions:
- Acetylcholine plays a central role in the age-associated loss of inhibitory control.
- This study provides novel insights into the neurobiological mechanisms underlying cognitive aging.
- Identified specific neuronal pathways for future research into interventions.
Related Concept Videos
01:26Alzheimer's Disease: Overview
612
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
612
01:22Alzheimer's Disease: Treatment
240
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
240
01:26Chemical Synapses
9.0K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.0K
01:23Role of Neurotransmitters in Memory
729
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
729
01:26Aging
145
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
145
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.0K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.0K